Articles
-
Oct 1, 2024 |
onlinelibrary.wiley.com | Petra Staubach |Raffi Tachdjian |Los Angeles USA |H. Li
Garadacimab provided consistent HAE attack prevention in manufacturer-funded post hoc pivotal Phase 3 data analysis. Protection from HAE attacks occurred by Week 1 after first administration.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →